Predictive oncology reports year end 2020 financial results, provides business update

Minneapolis, march 15, 2021 (globe newswire) -- predictive oncology (nasdaq: poai) – predictive oncology (nasdaq: poai), a knowledge-driven company focused on applying artificial intelligence (“ai”) to personalized medicine and drug discovery, today reported financial results for the year ended december 31, 2020 and provided an update on business activities.
POAI Ratings Summary
POAI Quant Ranking